An experimental study of therapeutic effect of Kangxiankeli on dimethyln itrosamine-induced rat liver fibrosis
Xie Chao-liang
Abstract
Xie Chao-liang
Abstract
Objective To investigate the therapeutic effect of Kangxiankeli(KXKL) on experimental liver fibrosis and to reveal its mechanism. Methods By establishing models of dimethylnitrosamine (DMN)-induced liver fibrosis in rat, we observed the effect of KXKL on content of TNF-α and γ-IFN. Results There was a decline of serum TNF-α and a increase of serum γ-IFN in KXKL group, compared to those of the DMN group (P0.05). Conclusions Our results suggest KXKL has therapeutic effect in DMN-induced rat liver fibrosis ,probably by regulating the cytokine contents of TNF-α and γ-IFN.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the therapeutic effect of Kangxiankeli(KXKL) on experimental liver fibrosis and to reveal its mechanism. Methods By establishing models of dimethylnitrosamine (DMN)-induced liver fibrosis in rat, we observed the effect of KXKL on content of TNF-α and γ-IFN. Results There was a decline of serum TNF-α and a increase of serum γ-IFN in KXKL group, compared to those of the DMN group (P0.05). Conclusions Our results suggest KXKL has therapeutic effect in DMN-induced rat liver fibrosis ,probably by regulating the cytokine contents of TNF-α and γ-IFN.
Key concepts: Medicine, Liver fibrosis, Therapeutic effect, Fibrosis, Rat model, Cytokine, Tumor necrosis factor alpha, Internal medicine